 | U. S. Preventive Services Task Force, U.S. Preventive Services Task Force - 1993 - 354 pages
...Dis 1983; 36:451-65. 43. Frick MH, Elo O, Haapa K, et al. Helsinki Heart Study: primary prevention trial with gemfibrozil in middle-aged men with dyslipidemia....incidence of coronary heart disease. N Engl J Med 1987; 317:1237-45. 44. Kronmal RA. Commentary on the published results of the Lipid Research Clinics... | |
 | Leon F. Fine - 1989 - 318 pages
...Atherosclerosis, 44: 355-365, 1982. 52. Frick MH, Elo O, Haapa K, Heinonen OP, Heinsalmi P, Helo P, Huttunen JK, et al: Helsinki Heart Study: Primary-prevention trial...gemfibrozil in middle-aged men with dyslipidemia. N Eng J Med, 317: 1237-1245, 1987. 53. Bridgeman JF, Rosen SM, Thorp JM: Complications during clofibrate... | |
 | National Research Council, Division on Earth and Life Studies, Commission on Life Sciences, Committee on Diet and Health - 1989 - 765 pages
...Malkonen, M. Manttari, S. Norola, A. Pasternack, J. Pikkarainen, M. Romo, T. Sjoblom, and EA Nikkila. 1987. Helsinki Heart Study: primary-prevention trial with...gemfibrozil in middle-aged men with dyslipidemia. Safety of lreatment, changes in risk factors, _^ ยง; 'ra and incidence of coronary heart disease. N. Engl. J.... | |
 | J. Morganroth, E. Neil Moore - 1989 - 320 pages
...heart disease to cholesterol lowering. JAMA 1984;251i365-374. 6. Frick MH, Elo O, Haapa K, Heinonen OP, et al. Helsinki Heart Study: primary-prevention trial...gemfibrozil in middle-aged men with dyslipidemia. N. Engl. J. Med. 1987;317:1237-1245. 7. The Coronary Drug Project Research Group. Clofibrate and niacin... | |
 | Mojtaba Esfahani, John B. Swaney - 1990 - 430 pages
...Malkonen, M. Manttari, S. Norola, A. Pasternack, J. Pikkarainen, M. Tomo, T. Sjoblom and E. Nikkila: Helsinki Heart Study: Primary-Prevention Trial with...Factors, and Incidence of Coronary Heart Disease. New England J. Med. 317: 1237 Fung, CH, AK Khachadurian, CH Wang, and IF Durr (1977) Regulation of... | |
 | O'grady - 1990 - 756 pages
...Helsinki Heart Study: primaryprevention trial with gemfibrozil in middle-aged men with dyslipidaemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. New Engl. J. Med., 317, 1237-45 Friedewald, WT, Levy, RI and Fredrickson, DS (1972). Estimation of... | |
 | Paul Boris Baltes, Margret M. Baltes - 1993 - 418 pages
...Manttari, M., Norola, S., Pasternack, A., Pikkarainen, J., Romo, M., Sjoblom, T., & Nikkila, EA (1987). Helsinki Heart Study: Primary-prevention trial with...gemfibrozil in middle-aged men with dyslipidemia. New England Journal of Medicine, 317, 1237-1245. Friedman, GD (1979). Decline in hospitalization for... | |
 | B. Rifkind - 1991 - 296 pages
...Pastemack. A., Pikkarainen, l., Romo, M., and Nikkila. EA (1987). Helsinki Heart Study: Primary, prevention trial with gemfibrozil in middle,aged men with dyslipidemia....incidence of coronary heart disease. N. Engl. J Med. 317:12371245. Group of Physicians of the Newcastle upon Tyne Region. ( 1 97 1 ). Trial of clofibrate... | |
| |
Frick MH, Elo O, Haapa K, et al: Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia; safety of treatment, changes in risk factors, and incidence of coronary heart disease. 
